China's pharmaceutical industry runs smoothly in the first three quarters-Zhejiang Jianfeng Pharmaceutical Co., Ltd.

China's pharmaceutical industry runs smoothly in the first three quarters

Release time:

2018-11-27

The growth rate of main business income is 3.8 percentage points higher than the national industrial average, and the profit growth rate is 1.7 percentage points lower than the national industrial average

● The export amount of chemical preparations was 18.14 billion yuan, up 34.9 year on year.

Enterprises mainly engaged in the production of API achieved a profit of 31.38 billion billion yuan, an increase of 32.5 over the same period last year, 19.5 percentage points higher than the industry average.

:: Increased supply tensions in the export and domestic markets of APIs, doubling the prices of some products and increasing profits.

According to the financial data of industrial enterprises released by the National Bureau of statistics, in the first three quarters of this year, the overall economic operation of China's pharmaceutical industry was stable, and the growth rate of main business income was 3.8 percentage points higher than the national industrial average; the profit growth rate was 1.7 percentage points lower than the national industrial average, and the growth gap was narrowing. The profit margin of main business income was 12.7, down 0.1 percentage points year-on-year; the asset-liability ratio was 41.7, up 0.7 percentage points year-on-year. From January to September this year, the export of chemical preparations increased by 34.9 compared with the same period last year, down from the previous eight months.

From January to September, the cumulative added value of the pharmaceutical industry (note) increased by 10.3 compared with the same period last year; in September, the industrial added value increased by 9.7 compared with the same period last year, 1.4 percentage points faster than in August. The main business income was 1948.64 billion yuan, a year-on-year increase of 13.3 percent, and the growth rate was 3.8 percentage points higher than the national average; the profit was 248.36 billion billion yuan, a year-on-year increase of 13%, and the growth rate was 1.7 percentage points lower than the national average; the export delivery value was 151.37 billion billion yuan, A year-on-year increase of 12.8 percent, a slowdown of 0.4 percentage points from January to August.

From January to September, the profit growth rate of the five pharmaceutical sub-industries of chemical raw materials, Chinese medicine decoction pieces, genetic engineering drugs and vaccine manufacturing, pharmaceutical excipients and packaging materials, and medical device industry was higher than the national average, increasing by 32.5 and 16 respectively.%, 54.6%, 13% and 29.6%. Among them, chemical raw materials and genetic engineering drugs and vaccine manufacturing profit growth continued to expand. The decline in profits in the pharmaceutical machinery industry further increased, down 81.6 percent year-on-year.

From January to September, the main business income of the chemical and pharmaceutical industry was 951.9 billion billion yuan, up 17.6 percent from the same period last year, 4.3 percentage points higher than the industry average; the profit was 122.95 billion billion yuan, up 14.3 percent from the same period last year, 1.3 percentage points higher than the industry average; the export delivery value was 69.62 billion billion yuan, up 18.3 percent from the same period last year, and the growth rate was 2 percentage points lower than that from January to August.

In the case of strict environmental protection in all parts of the country, there are two situations that affect the production of APIs: one is the suspension or closure of API production enterprises that do not meet the environmental protection standards; the other is the suspension or closure of chemical raw material production enterprises that do not meet the environmental protection standards, resulting in a shortage of raw materials and unable to produce. As a result, the export of APIs and the domestic market supply tensions intensified, some product prices doubled, profits increased.

From January to September, the main business income of enterprises mainly engaged in the production of raw materials reached 303.36 billion billion yuan, an increase of 13 percent over the same period last year, and profits reached 31.38 billion billion yuan, an increase of 32.5 percent over the same period last year, 19.5 percentage points higher than the industry average. The value of export delivery increased by 13.4 year-on-year, and the growth rate was 1.7 percentage points lower than that from January to August; accounts receivable increased by 18% year-on-year, and the growth rate was 2.4 percentage points larger than that at the end of August; the number of loss-making enterprises increased by 16 year-on-year, with a loss of 2.64 billion billion yuan, a year-on-year increase of 26.8 percentage points, an increase of 10.6 percentage points over the end of August. The profit margin of the main business income of enterprises dominated by API production was 10.3, 2.4 percentage points lower than the industry average.

From January to September, the main business income of enterprises mainly engaged in the production of chemical preparations was 648.54 billion yuan, an increase of 19.8 percent over the same period last year, an increase of 6.6 percentage points higher than the industry average; profits were 91.57 billion billion yuan, an increase of 9.2 percent over the same period last year, an increase of 1.5 percentage points over January to August; the export amount of preparation products was 18.14 billion billion yuan, an increase of 34.9 percent over the same period last year, the growth rate narrowed by 8.5 percentage points from January to August; accounts receivable increased by 16.7 year-on-year, an increase of 0.5 percentage points from the end of August. The number of loss-making enterprises increased by 4 over the same period last year, and the loss increased by 7% year-on-year. The profit margin of the main business income of enterprises mainly engaged in the production of chemical preparations was 14.1, which was 1.4 percentage points higher than the industry average.

(China Chemical Pharmaceutical Industry Association)

Note: The pharmaceutical industry consists of chemical raw materials, chemical preparations, proprietary Chinese medicines, processing of Chinese herbal pieces, manufacturing of biopharmaceuticals, manufacturing of genetically engineered drugs and vaccines, sanitary materials and medical supplies, pharmaceutical excipients and packaging materials, pharmaceutical machinery and medical equipment industry.

Related News

SAF Coolest v1.3.1.1 设置面板XRBSX-ZEJN-JAAZE-ZWD

无数据提示